Dana CPM Chlorpheniramine Tablets

DANA-CPM

CHLORPHENIRAMINE TABLETS 4 mg B.P.

 

Composition

Each tablet contains:

Chlorpheniramine B.P. 4 mg

 

Indications

1. Seasonal allergic rhinitis and conjunctivitis

2. Acute and chronic urticaria

3. Atopic dermatitis

4. Allergic asthma, angioedema

5. Systemic anaphylaxis

 

Dosage

Chlorpheniramine maleate is given in doses of 4 mg every 4 to 6 hours up to a maximum of 24 mg daily. Doses recommended for children are: 1 to 2 years, 1 mg twice daily; 2 to 5 years, 1 mg every 4 to 6 hours ( maximum 6 mg daily); 6 to 12 years, 2 mg every 4 to 6 hours (maximum 12 mg daily).

 

Side Effects

The symptomatic adverse effect with therapeutic dose (15-25 mg daily) of chlorpheniramine maleate include slight to moderate drowsiness, dry mouth, and blurred vision which all represent the undesirable pharmacological efcets of the drug. These effects occur in up to one-thrid of patients, and they are less frequent than those reported after therapeutic doses of diphenhydramine and triprolidine.

 

Contraindications

1. Known allergy to chlorpheniramine.

2. Not recommended to be used during pregnancy.

 

Presentation

Pack of 1000 Tablets.

 

Manufacture by

DANA PHARMACEUTICALS LIMITED

Shiroro Dam Road, Post Box No. 3195, Maitumbi, Minna,

Niger State, Nigeria.

Leave a Reply